About this trial
The goal of this study is to determine the impact of MVM supplementation on clinical and biochemical markers associated with healthy aging, with a particular focus on mitochondrial function and metabolism. Specifically, changes in mitochondrial respiration using isolated blood cells will be measured. This method has been used to compare with various other age-related markers of health such as physical function, gait speed, and resting metabolic rate. It is hypothesize that MVM supplementation will impact the function of blood cells. MVM supplementation impacts other markers of health, including serum nutrient levels, metabolomic profiles, physical function, and skeletal muscle composition and quality will be explored. These comprehensive assessments will provide insights into the potential benefits of MVM supplementation for healthy aging and address critical gaps in our understanding of its immediate effects. Further, this study will aid in the understanding of how multivitamin supplements can support heathy aging in mid-life adults, a key time to start including wellness programs in people's lives.
The study cohort will consist of 150 sedentary men and women aged 40-60-years of age. A double-blind, three-arm, placebo-controlled randomized clinical trial will be conducted. Participants will receive a daily oral tablet containing one of two possible formulations of vitamins and minerals or a placebo. The three groups will be MVM "GOLD" blend formula, the US Restage MVM "US CORE", and the placebo group.
Eligibility criteria
Qualifiers
IPAQ-SF categorical score of low or moderate physical activity (indicating sedentary lifestyle).
Stated willingness to comply with all study procedures and availability for the duration of the study
Between 40-60 years of age
BMI ≥18.5 and ≤32 kg/m2
Disqualifiers
Is pregnant or nursing.
Current smoker.
Diabetes (FPG > 180 mg/dL or A1c>8)
Heart or cardiovascular condition, including coronary artery disease, congestive heart failure, diagnosed abnormality of heart rhythm, atrial fibrillation and/or a history of myocardial infarction
Trial design
Treatments tested in this trial
- MVM Core Blend
- MVM Gold Blend
- Placebo
Treatment groups
Sponsors and collaborators
University of California, San Diego
Lead sponsor
HALEON
Collaborator